World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   801 records for 232 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
RecruitingYesNCT03383211
Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers
19/12/2017 
RecruitingNoCTRI/2017/09/009894
Heat therapy(agnikarma) in Tennis Elbow
22-09-2017Yes
Not recruitingYesNCT03230292
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
Recruitment statusMain IDPublic titleDate of registrationResults available
Not RecruitingEUCTR2016-002934-57-DE This is a study to evaluate the long-term safety, tolerability and efficacy of bimekizumab in adult patients with chronic plaque psoriasis. 03/11/2016 
24/07/2017 
RecruitingYesNCT03219957
Study of AT-527 in Healthy and HCV-Infected Subjects
13/07/2017 
RecruitingYesNCT03215277
Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis.
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-000957-37-GR Study to test the efficacy and safety of Bimekizumab and Certolizumab Pegol in patients with active ankylosing spondylitis 13/09/2017 
AuthorisedEUCTR2017-000957-37-DE Study to test the efficacy and safety of Bimekizumab and Certolizumab Pegol in patients with active ankylosing spondylitis 14/07/2017Yes
05/07/2017 
AuthorisedYesEUCTR2017-001082-24-LV
An international study at different study sites providing a drug called cemdisiran (ALN-CC5) to patients with Atypical Hemolytic Uremic Syndrome by a subcutaneous injection 20/06/2017 
AuthorisedYesEUCTR2017-001061-24-DK
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-042 in Patients with Type 2 Diabetes 17/05/2017Yes
AuthorisedYesEUCTR2016-004834-11-DK
A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 or 180 mg bid for 12 weeks in combination with methotrexate, in DMARD-naïve patients with early rheumatoid arthritis 11/05/2017 
RecruitingYesNCT03139136
Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis
26/04/2017 
Not recruitingYesACTRN12617000557336
A study to determine the safety and anti-viral activity of ARB-1740 in patients with chronic hepatitis B virus (HBV) infection.
21/04/2017 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history